The GME squeeze should’ve been an obvious topping indicator in the market. It marked the peak of stock market excess… Alongside all the hot biotechs, SPAC runners, and tech stocks that don’t earn anything shooting straight to the upside. Now, the market’s looking a little different. ARKK is down 70% and the Nasdaq is off […]